Search For "bharat biotech"
COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week
Updated : 4 years, 8 months ago IST
New Delhi [India], July 23 (ANI): As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday.
Read More
Bharat Biotech dossier under review for Covaxin emergency use listing: WHO
Updated : 4 years, 8 months ago IST
New Delhi [India], July 19 (ANI): Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use Listing (EUL) of Covaxin is under review by the technical experts for consideration, Dr Poonam Kh
Read More
Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 12 (ANI): With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global bod
Read More
EUL to Covaxin from WHO expected in first week of August: Sources
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], July 10 (ANI): The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce it in the first week of August.
Read More
Union Minister Mansukh Mandaviya visits COVID-19 vaccine manufacturing fac
Updated : 4 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 4 (ANI): Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Sunday visited the COVID-19 vaccine manufacturing facilities of Zydus Cadila and Hester Biosciences in Gujarat.
Read More
After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will
Updated : 4 years, 8 months ago IST
New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from the World Healt
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
Congress says, why Centre 'conspicuously silent' on Covaxin pricing contro
Updated : 4 years, 8 months ago IST
New Delhi [India], July 3 (ANI): The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is "conspicuously silent" on the matter.
Read More
Bharat Biotech to soon start Covaxin manufacturing facility in Bengaluru
Updated : 4 years, 9 months ago IST
New Delhi [India], June 30 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that the company hopes to start manufacturing its COVID-19 vaccine Covaxin in Bengaluru soon.
Read More
Covaxin booster dose trial results likely to come by November, say sources
Updated : 4 years, 9 months ago IST
New Delhi [India], June 30 (ANI): Results of trials of the third booster dose of Bharat Biotech's COVID-19 vaccine Covaxin is expected to come by November this year, sources told ANI.
Read More
Bharat Biotech denies receiving advance payments, supplying vaccines to Br
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 30 (ANI): Issuing clarification on COVAXIN pricing controversy in Brazil, Bharat Biotech on Tuesday said it followed a step-by-step regulatory approval process during the eight-month period, but the company has neither received any advance payments nor
Read More
Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US
Updated : 4 years, 9 months ago IST
Washington DC [US], June 30 (ANI): The National Institute of Health (NIH) in the United States has found that Bharat Biotech's COVAXIN vaccine generates antibodies that effectively neutralize both Alpha and Delta variants of COVID-19.
Read More